ISO 14630:2024

Overview

ISO 14630:2024 - "Non‑active surgical implants - General requirements" is the Level 1 ISO standard specifying baseline safety and performance requirements for non‑active surgical implants. It defines requirements for intended performance, design attributes, materials, design evaluation, manufacture, sterilization, packaging and information supplied by the manufacturer. It does not apply to dental implants, dental restorative materials, transendodontic/transradicular implants, intra‑ocular lenses or implants that utilize viable animal or human tissue.

This fifth edition updates and expands the 2012 edition to clarify scope, add clinical‑evaluation definitions, strengthen material selection and risk analysis expectations, expand design evaluation (pre‑clinical, clinical, post‑market) and introduce patient record labels and implant cards.

Key topics and requirements

• Intended performance: define indications, contraindications and target patient population as part of device specification.
• Design attributes: systematic consideration of mechanical, dimensional, interface and safety characteristics during design.
• Selection of materials: use of a risk‑based approach (aligned with ISO 14971) to justify materials and assess biocompatibility and toxicological risk.
• Design evaluation: expanded coverage of pre‑clinical testing, clinical evaluation/clinical investigation and post‑market surveillance requirements.
• Manufacture and cleanliness: manufacturing controls to ensure implant cleanliness and conformity with design.
• Sterilization: requirements for implants supplied sterile, non‑sterile and re‑sterilizable devices; references to validated sterilization methods and control of sterilization residuals.
• Packaging: protection from damage, maintenance of sterility, and determination of use‑by dates.
• Information supplied: marking, labeling, instructions for use, patient record labels and implant cards to support traceability and safe use.
• Testing and demonstration: tests needed to demonstrate compliance with the above requirements and conformity to applicable Level 2/3 standards.

Practical applications and users

ISO 14630:2024 is used by:

• Medical device manufacturers for design controls, material selection, sterilization strategy and labelling requirements for non‑active implants.
• Regulatory affairs and quality managers to align dossiers with international expectations (often used alongside ISO 13485 and ISO 14971).
• Test laboratories and contract sterilizers to understand required validations and residual controls.
• Notified bodies and regulators when assessing conformity and clinical evidence.
• Clinicians and procurement specialists to verify manufacturer information (IFU, implant cards) needed for safe implantation and traceability.

Related standards (commonly referenced)

• ISO 14971 (risk management)
• ISO 10993 series (biological evaluation)
• ISO 11135 / ISO 11137 (sterilization validation)
• ISO 11607 (packaging for terminally sterilized devices)
• ISO 14155 (clinical investigation)
• ISO 13485 (quality management systems)

By applying ISO 14630:2024 together with applicable Level 2/Level 3 standards, stakeholders can ensure robust, risk‑based development and safe clinical use of non‑active surgical implants.